Dimension Therapeutics, Inc. Accounts Receivable
Dimension Therapeutics, Inc. had Accounts Receivable of $2.78 million as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2017-11-06
- 2017-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $2.78M.
- 2017-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.10M.
- 2017-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $2.37M.
- 2016-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $1.89M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2017-09-30 | $2.78M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $3.10M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.37M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.89M 10-Q · filed 2017-11-06 |
| 2016-09-30 | $1.81M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.32M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $1.26M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $143.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $2.09M 10-Q · filed 2015-12-04 |
| 2014-12-31 | $1.97M 10-K · filed 2016-03-24 |